Double Medical Technology Inc. (SHE:002901)

Double Medical Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,363	2,119	1,525	1,428	1,989	1,583
Other Revenue	18.56	16.7	8.39	5.94	5.02	3.39
Revenue	2,382	2,136	1,533	1,434	1,994	1,587
Revenue Growth (YoY)	36.29%	39.30%	6.91%	-28.09%	25.68%	26.21%
Cost of Revenue	759.3	710.15	541.52	344.6	319.12	230.65
Gross Profit	1,623	1,425	991.6	1,089	1,675	1,356
Selling, General & Admin	812.96	769.03	690.5	788.18	746.94	565.3
Research & Development	330.85	306.87	285.28	256.72	167.07	128.02
Other Operating Expenses	39.12	9.1	-2.51	15.77	27.52	21.51
Operating Expenses	1,188	1,091	972.13	1,059	957.77	723.13
Operating Income	434.39	334.38	19.47	30.9	717.45	633.08
Interest Expense	-5.87	-6.49	-7.16	-3.1	-0.55	-
Interest & Investment Income	37.11	44.78	39.65	37.23	34.63	28.53
Currency Exchange Gain (Loss)	3.87	-11.35	0.77	7.62	-5.87	-10.05
Other Non Operating Income (Expenses)	0.33	-0.16	-0.54	-0.32	-0.2	-0.14
EBT Excluding Unusual Items	469.83	361.16	52.19	72.33	745.45	651.42
Impairment of Goodwill	-0.1	-0.5	-0.86	-1.37	-0.91	-
Gain (Loss) on Sale of Investments	16.27	3.11	5.6	1.77	1.22	2.52
Gain (Loss) on Sale of Assets	0.26	0.27	0.3	-1.73	-0	-0.12
Asset Writedown	-0.44	-0.43	-0.02	-0.54	-0.03	-0.06
Legal Settlements	-	-	-	-	-19.1	-2.4
Other Unusual Items	78.27	64.81	42.51	77	75.88	58.28
Pretax Income	564.1	428.41	99.72	147.46	802.51	709.63
Income Tax Expense	70.37	43.12	13.4	37.89	111.01	94.88
Earnings From Continuing Operations	493.72	385.29	86.32	109.57	691.5	614.75
Minority Interest in Earnings	-30.91	-28.49	-27.36	-17.01	-18.19	-9.07
Net Income	462.82	356.8	58.96	92.56	673.31	605.68
Net Income to Common	462.82	356.8	58.96	92.56	673.31	605.68
Net Income Growth	346.44%	505.16%	-36.30%	-86.25%	11.16%	30.12%
Shares Outstanding (Basic)	411	415	421	421	401	401
Shares Outstanding (Diluted)	411	415	421	421	403	401
Shares Change (YoY)	-2.36%	-1.49%	0.10%	4.35%	0.52%	-0.04%
EPS (Basic)	1.13	0.86	0.14	0.22	1.68	1.51
EPS (Diluted)	1.13	0.86	0.14	0.22	1.67	1.51
EPS Growth	357.24%	514.29%	-36.36%	-86.83%	10.60%	30.17%
Free Cash Flow	384.65	171.84	-231.82	-156.63	438.15	418.64
Free Cash Flow Per Share	0.94	0.41	-0.55	-0.37	1.09	1.04
Dividend Per Share	0.500	0.500	0.250	-	0.500	0.800
Dividend Growth	100.00%	100.00%	-	-	-37.50%	33.33%
Gross Margin	68.12%	66.75%	64.68%	75.97%	84.00%	85.47%
Operating Margin	18.24%	15.66%	1.27%	2.15%	35.97%	39.90%
Profit Margin	19.43%	16.71%	3.85%	6.45%	33.76%	38.17%
Free Cash Flow Margin	16.15%	8.05%	-15.12%	-10.92%	21.97%	26.38%
EBITDA	553.56	446.79	121.28	117.12	782.07	683.41
EBITDA Margin	23.24%	20.92%	7.91%	8.17%	39.22%	43.07%
D&A For EBITDA	119.17	112.42	101.81	86.22	64.62	50.33
EBIT	434.39	334.38	19.47	30.9	717.45	633.08
EBIT Margin	18.24%	15.66%	1.27%	2.15%	35.97%	39.90%
Effective Tax Rate	12.47%	10.06%	13.44%	25.70%	13.83%	13.37%
Revenue as Reported	2,382	2,136	1,533	1,434	1,994	1,587

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.